Home
Kynam Capital Management reported a 5.7% stake in Viridian Therapeutics, Inc.\DE VRDN · 0 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5.7%
- Last report
- 1.54% · filed 26/02/17
- Shares held
- 0 sh
- Class
- Common Stock, $0.01 par value
- Holder
- Kynam Capital Management
- Event date
- 26/06/30
- Filed
- 26/08/14
5.7% stake · +4.2pp from the last report
- Stake
- 5.7%
- Last report
- 1.54%
- Since last report
- +4.2pp
Viridian Therapeutics, Inc.\DE trades, last 26 weeks
What else happened in Viridian Therapeutics, Inc.\DE around then
Filed or reported within 30 days of the trade day · 05/31~07/30Kynam Capital Management's other 5% stake reports
- Kynam Capital Management
5% stakeVera Therapeutics
5% stakeVera Therapeutics
VERA
4.01% stake
0 sh
4.01% stake
Filed 08/14
- Kynam Capital Management
5% stakeCytomX Therapeutics
5% stakeCytomX Therapeutics
CTMX
9.96% stake
0 sh
9.96% stake
Filed 08/14
- Kynam Capital Management
5% stakeCelldex Therapeutics
5% stakeCelldex Therapeutics
CLDX
6.78% stake
0 sh
6.78% stake
Filed 08/14
- Kynam Capital Management
5% stakeBurning Rock Biotech
5% stakeBurning Rock Biotech
BNR
13.97% stake
0 sh
13.97% stake
Filed 05/15
- Kynam Capital Management
5% stakeCelldex Therapeutics
5% stakeCelldex Therapeutics
CLDX
8.77% stake
0 sh
8.77% stake
Filed 05/15
